DESMOPRESSIN ACETATE (desmopressin acetate) by Ferring Pharmaceuticals is clinical pharmacology desmopressin acetate injection 4 mcg/ml contains as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. Approved for hemophilia a with factor viii coagulant activity levels equal to, less than 5%, for the treatment of hemophilia b and 2 more indications. First approved in 2020.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Desmopressin Acetate Injection 4 mcg/mL contains as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. One mL (4 mcg) of Desmopressin Acetate Injection(desmopressin acetate) solution has an antidiuretic activity of about…
Worked on DESMOPRESSIN ACETATE at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Desmopressin Acetate 0.2 mg Tablets, Fasting
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo